Zacks Investment Research upgraded shares of DYNAVOX INC-A (DVOX) from NEUTRAL to OUTPERFORM on February 19, 2013, with a target price of $0.30.
DynaVox Inc. is engaged in developing and marketing software, devices and content to assist people in overcoming their speech, language or learning disabilities. The Company's speech generating devices are used by those who are unable to speak, such as adults with amyotrophic lateral sclerosis, or ALS, often referred to as Lou Gehrig's disease, strokes or traumatic brain injuries and children with cerebral palsy, autism or other disorders. Its portfolio of speech generating devices provides users with a broad range of features and designs and makes use of an array of adaptive technology that permits users with physical or cognitive limitations to access and control the devices. DynaVox's mission is to enable its customers to realize their full communication and education potential by developing industry-leading devices, software and content and by providing the services to support them.
Get all Zacks Research Reports and be alerted to fast-breaking buy and sell opportunities every trading day.
To get a free copy of the research report on DYNAVOX INC-A (DVOX),
click here.
For more information about research offerings from Zacks Investment Research, visit
Zacks.com .
Be the first to comment